Your browser doesn't support javascript.
loading
Clinical Development of Therapeutic Agents for Hospitalized Patients With Influenza: Challenges and Innovations.
King, James C; Beigel, John H; Ison, Michael G; Rothman, Richard E; Uyeki, Timothy M; Walker, Robert E; Neaton, James D; Tegeris, John S; Zhou, James A; Armstrong, Kimberly L; Carter, Wendy; Miele, Peter S; Willis, Melissa S; Dugas, Andrea F; Tracy, LaRee A; Vock, David M; Bright, Rick A.
Affiliation
  • King JC; US Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Washington, District of Columbia.
  • Beigel JH; National Institutes of Health, Division of Microbiology and Infectious Diseases, Bethesda, Maryland.
  • Ison MG; Divisions of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Rothman RE; Department of Emergency Medicine, Johns Hopkins Hospital, Johns Hopkins University School of Medicine, Baltimore, Maryland; for the ED Influenza Research Consortium.
  • Uyeki TM; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Walker RE; US Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Washington, District of Columbia.
  • Neaton JD; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis.
  • Tegeris JS; US Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Washington, District of Columbia.
  • Zhou JA; US Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Washington, District of Columbia.
  • Armstrong KL; US Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Washington, District of Columbia.
  • Carter W; US Food and Drug Administration, Division of Antiviral Products, Silver Spring, Maryland.
  • Miele PS; US Food and Drug Administration, Division of Antiviral Products, Silver Spring, Maryland.
  • Willis MS; US Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Washington, District of Columbia.
  • Dugas AF; Shady Grove Medical Center, Rockville, Maryland.
  • Tracy LA; US Food and Drug Administration, Division of Antiviral Products, Silver Spring, Maryland.
  • Vock DM; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis.
  • Bright RA; US Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Washington, District of Columbia.
Open Forum Infect Dis ; 6(4): ofz137, 2019 Apr.
Article in En | MEDLINE | ID: mdl-31037242
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Open Forum Infect Dis Year: 2019 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Open Forum Infect Dis Year: 2019 Document type: Article Country of publication: United States